Vitamin B17 Effects ON
Anti-Cancer Effects of Amygdalin
Vitamin B-17/Amygdalin are a molecule made up of four parts: 2 parts Glucose, 1 part Benzaldahyde, 1 part Hydrogen Cyanide (which is also found in vitamin B-12).
Malignant cancer cells are specifically vulnerable to cyanogenic glycosides because of two characteristics: a higher level of beta-glucosidases and beta-glucuronidase compared to normal cells, which would lead to a more rapid intracellular release of cyanide from laetrile or amygdalin and a deficiency in rhodanese, an enzyme that converts cyanide into the harmless compound thiocyanate.
It is important to note that the body has the proper compounds to either neutralize the B17 molecules or to unlock to them at the site of cancer. This is because the enzyme rhodanese is found in normal healthy cells and it automatically neutralize the Benzaldahyde and Hydrogen Cyanide, converting them into harmless compounds which the body will then excrete.
Rhodanese is found everywhere in the body except for in (or around) cancer cells or tumors. In contrast, Beta-Glucosidase is found only at the site of cancer and is referred to as the “unlocking enzyme” since it will unlock the cyanide and benzaldahyde at the site of cancerous cells and tumors. When glucose delivers the B-17 molecules to the cancerous cells, they are unable to neutralize the cyanide since they lack the rhodanese enzyme. Instead, the cyanide and benzaldahyde are released at the site of cancer allowing them to target the cancer cells directly. This action also apply to cyst and fibroid in the ovary.
Reference – Huaping Z, Liwen C, Wenbin L, Hanchu L (2004) Effect of amygdalin on the proliferation of hyperoxia-exposed type II alveolar epithelial cells isolated from premature rat. J Huazhong Univ Sci Technolog Med Sci 24: 223-225.